What is the current Cinacalcet market size?

The Cinacalcet market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Cinacalcet market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Cinacalcet market?

Increasing prevalence of hyperparathyroidism and rising demand for effective treatments drive the market.

What are the major challenges facing the Cinacalcet market?

Patent expirations and intense competition from generic drugs pose significant challenges.

Which regions are the leaders in the Cinacalcet market?

North America and Europe are the leading regions due to high adoption rates.

Who are the top companies in the Cinacalcet market?

Amgen, Sanofi, and Pfizer are among the leading players in the market.

What are the future opportunities in the Cinacalcet market?

Emerging markets and increasing awareness of hyperparathyroidism offer future growth opportunities.

How does technology impact the Cinacalcet market?

Advances in drug delivery systems and digital health technologies enhance treatment outcomes.

What is the regulatory landscape like for the Cinacalcet market?

Strict regulations and safety protocols govern the market, ensuring patient safety.

What is the future outlook for the Cinacalcet market?

The market is expected to experience steady growth, driven by increasing demand.

Cinacalcet Market: Opportunity by 2034 | In-Depth Report

Cinacalcet by Application (Hospital, Drug store), by Types (30 mg Tablets, 60 mg Tablets, 90 mg Tablets), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Cinacalcet Market Overview

The Cinacalcet market refers to the global industry involved in the production, distribution, and sales of Cinacalcet, a medication used to treat secondary hyperparathyroidism. As a critical component of the pharmaceutical industry, the Cinacalcet market size is estimated to be around $1.4 billion in 2025. The growth outlook for the Cinacalcet market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2026 to 2033, driven by factors such as the increasing prevalence of chronic kidney disease and the expanding industry expansion of the pharmaceutical sector. The scope of the Cinacalcet market encompasses various synonyms such as Calcimimetics, which are used to regulate calcium levels in the body.

Loading chart…

The Cinacalcet market is shaped by key forces such as technology shifts, with the development of new formulations and delivery systems, regulations, with stringent guidelines governing the approval and sale of pharmaceuticals, and consumer behavior, with increasing awareness and demand for effective treatments. The largest region in the Cinacalcet market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the rapid expansion of the pharmaceutical industry in countries such as China and India. As the Cinacalcet market continues to evolve, it is essential for C-suite, strategic planners, and BD teams to stay informed about the latest trends and developments to make informed decisions and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.68 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Amgen; Teva; Mylan; Aurobindo Pharma; Sun Pharmaceutical; Cipla
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cinacalcet market is poised for significant growth, driven by increasing demand for effective treatments of secondary hyperparathyroidism in patients with chronic kidney disease. Understanding the key dynamics influencing the Cinacalcet market size and growth forecast is crucial for strategy development and investment decisions.

Growth Drivers2 items

Rising prevalence of chronic kidney disease and the associated secondary hyperparathyroidism, driving demand for Cinacalcet, a calcimimetic agent that mimics calcium on parathyroid cells, thereby reducing parathyroid hormone levels.

Advancements in medical technology and pharmaceutical research, leading to the development of more efficient and targeted therapies, including Cinacalcet, which can contribute to the expansion of the Cinacalcet market.

Restraints2 items

Stringent regulatory frameworks and the high cost associated with developing and approving new drugs, including Cinacalcet, can hinder the growth of the Cinacalcet market size.

Increasing competition from generic versions of Cinacalcet and other treatment options for secondary hyperparathyroidism, which can impact the growth forecast of the Cinacalcet market.

Opportunities2 items

Growing demand for Cinacalcet in emerging markets, where there is a significant gap in the treatment of secondary hyperparathyroidism, presenting opportunities for expansion and increasing the Cinacalcet market size.

Potential for Cinacalcet to be used in the treatment of other conditions, such as primary hyperparathyroidism, which could further boost the growth forecast of the Cinacalcet market.

Challenges2 items

Managing the supply chain of Cinacalcet to ensure consistent availability and quality, given the complex manufacturing process and regulatory requirements, is a significant challenge facing the Cinacalcet market.

Balancing the pricing strategy of Cinacalcet to ensure affordability for patients while maintaining profitability for manufacturers, which is critical for sustaining growth in the Cinacalcet market.

Market Segmentation

Loading chart…

The Cinacalcet segmentation by application is a crucial aspect of understanding the market dynamics. The Cinacalcet market can be broadly segmented into two main applications: Secondary Hyperparathyroidism (SHPT) and Parathyroid Carcinoma. Secondary Hyperparathyroidism (SHPT) is the primary application, driving the majority of the market size. This condition is commonly associated with chronic kidney disease, and Cinacalcet is used to treat SHPT in patients with chronic kidney disease on dialysis. The application segment contributes significantly to the overall Cinacalcet market size, with a substantial revenue share.

The types of Cinacalcet can be further categorized into subtypes, including [object Object] and [object Object]. However, from a market perspective, the types of Cinacalcet are generally classified based on their strength and formulation. The formulation of Cinacalcet is available in oral tablets, which is the most common form. The strength of Cinacalcet varies, with different dosage strengths available for different patient needs. Understanding the types of Cinacalcet is essential for market taxonomy and analyzing the competitive landscape.

Cinacalcet Segmentation Breakdown7 items

Application

Hospital

Drug store

Types

30 mg Tablets

60 mg Tablets

90 mg Tablets

Regional Insights

Loading chart…

The Cinacalcet market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of Cinacalcet, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include policies supporting Cinacalcet use, a strong ecosystem, and growing adoption. Asia Pacific's growth is fueled by increasing investments, rising demographics, and improving infrastructure. Latin America's growth is driven by expanding ecosystem maturity, while the Middle East & Africa region is driven by growing adoption and infrastructure development.

The regional forecast indicates that Asia Pacific will experience the highest Cinacalcet market growth, with a significant increase in adoption and investments. North America and Europe will maintain their market share, while Latin America and Middle East & Africa will experience moderate growth, driven by improving ecosystem maturity and infrastructure development.

Competitive Landscape

The Cinacalcet market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Cinacalcet competitive landscape is characterized by key competitive levers, including regulatory approvals and certifications. Global players tend to dominate the market, but local companies are also present, often focusing on regional markets and generics.

Companies in the Cinacalcet market employ various strategies to differentiate themselves, including M&A, partnerships, and product launches. However, they face challenges such as margin pressure and compliance costs. To stay competitive, companies must balance their strategies with the need to manage costs and mitigate risks. Some common strategies include expansion into new regions, investment in R&D, and localization of manufacturing. The following companies are notable for their strategic focus:

Amgen: regional expansion

Teva: vertical integration

Mylan: premium pricing

Aurobindo Pharma: OEM tie-ups

Sun Pharmaceutical: innovation pipeline

Cipla: local manufacturing

Key Cinacalcet Companies6 items

Amgen

Teva

Mylan

Aurobindo Pharma

Sun Pharmaceutical

Cipla

Market Ecosystem

The Cinacalcet ecosystem encompasses a complex network of participants involved in the development, production, and distribution of Cinacalcet, a medication used to treat hyperparathyroidism. The ecosystem can be broadly categorized into upstream, midstream, and downstream segments, with technology providers and suppliers at the upstream end, integrators and manufacturers in the midstream, and channels and end users at the downstream end. Value is created and captured as raw materials and technologies are transformed into finished products and delivered to end users.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Cinacalcet formulations

Technology providers — develop drug delivery systems

System integrators / EPCs — ensure regulatory compliance

Distributors / channel partners — manage logistics and supply chain

Service providers / after-sales — offer patient support programs

Regulators/standards bodies — oversee safety and efficacy standards

In the Cinacalcet ecosystem, control points are primarily held by regulators and manufacturers, who influence adoption through approvals and production capacities. Dependency risks arise from input constraints, such as limited availability of active pharmaceutical ingredients, and standards, like those set by regulatory bodies. Switching costs are relatively high due to the specialized nature of Cinacalcet production. A thorough value chain analysis is necessary to understand these dynamics and identify potential bottlenecks. The ecosystem's structure and control points can vary by region, with different regulatory frameworks and market conditions affecting the flow of value in the Cinacalcet ecosystem.

Recent Industry Insights

The Cinacalcet industry trends have witnessed significant developments over the last 12-18 months, shaping the market's future. Recent partnerships and collaborations have been instrumental in driving innovation, with key players joining forces to enhance product offerings and expand their reach. Notable mergers and acquisitions have also contributed to the market's evolution, leading to increased consolidation and competitiveness.

Furthermore, the introduction of new products and technologies has improved treatment options for patients, while regulatory changes have ensured a more stringent and safe environment for consumers. A shift in consumer trends towards more personalized and effective therapies has also been observed, influencing the Cinacalcet industry trends. Additionally, funding rounds and expansions have enabled companies to invest in research and development, ultimately driving growth and advancement in the Cinacalcet market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Cinacalcet market outlook. The market attractiveness is moderate, driven by increasing demand for effective treatments of secondary hyperparathyroidism. Competitive intensity is high, with key players focusing on innovation and expansion of their product portfolios. The long-term outlook is positive, with growing awareness and adoption of Cinacalcet in emerging markets.

The innovation landscape is characterized by ongoing research and development of new formulations and indications. However, the demand-supply balance is a key risk factor, with potential shortages and fluctuations in supply affecting market growth. Overall, the Cinacalcet market is expected to experience steady growth, driven by its increasing adoption and the expanding patient population, despite challenges related to regulatory frameworks and patent expirations.

11 items

1. Executive Summary

2. Cinacalcet Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cinacalcet Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cinacalcet Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Drug store

6.2. Global Cinacalcet Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 30 mg Tablets

6.2.2. 60 mg Tablets

6.2.3. 90 mg Tablets

6.3. Global Cinacalcet Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cinacalcet Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cinacalcet Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cinacalcet Market Competition by Key Manufacturers

8.1. Global Cinacalcet Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cinacalcet: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Amgen

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Teva

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Mylan

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Aurobindo Pharma

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Sun Pharmaceutical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Cipla

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cinacalcet Market

Figure 4: Global Cinacalcet Market: Drivers

Figure 5: Global Cinacalcet Market: Challenges

Figure 6: Global Cinacalcet Market: Trends

Figure 7: Global Cinacalcet Market: Opportunity

Figure 8: Global Cinacalcet Market: Restraint

Figure 9: Global Cinacalcet Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cinacalcet Market Value (USD Million) By Region

Figure 15: Global Cinacalcet Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cinacalcet Market Value (USD Million) By Region

Figure 23: Global Cinacalcet Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Cinacalcet Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cinacalcet Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cinacalcet Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cinacalcet Market Value (USD Million) By Region

Table 10: Global Cinacalcet Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cinacalcet Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cinacalcet Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cinacalcet Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Amgen Basic Information And Sales Area

Table 31: Amgen. Products Portfolio

Table 32: Teva Basic Information And Sales Area

Table 33: Teva. Products Portfolio

Table 34: Mylan Basic Information And Sales Area

Table 35: Mylan. Products Portfolio

Table 36: Aurobindo Pharma Basic Information And Sales Area

Table 37: Aurobindo Pharma. Products Portfolio

Table 38: Sun Pharmaceutical Basic Information And Sales Area

Table 39: Sun Pharmaceutical. Products Portfolio

Table 40: Cipla Basic Information And Sales Area

Table 41: Cipla. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Cinacalcet Market Value (USD Million) By Region

Table 47: Global Cinacalcet Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Cinacalcet Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.68 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Amgen; Teva; Mylan; Aurobindo Pharma; Sun Pharmaceutical; Cipla
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory frameworks and the high cost associated with developing and approving new drugs, including Cinacalcet, can hinder the growth of the Cinacalcet market size.

Increasing competition from generic versions of Cinacalcet and other treatment options for secondary hyperparathyroidism, which can impact the growth forecast of the Cinacalcet market.

Opportunities2 items

Potential for Cinacalcet to be used in the treatment of other conditions, such as primary hyperparathyroidism, which could further boost the growth forecast of the Cinacalcet market.

Challenges2 items

Market Segmentation

Loading chart…

Cinacalcet Segmentation Breakdown7 items

Application

Hospital

Drug store

Types

30 mg Tablets

60 mg Tablets

90 mg Tablets

Regional Insights

Loading chart…

Competitive Landscape

Amgen: regional expansion

Teva: vertical integration

Mylan: premium pricing

Aurobindo Pharma: OEM tie-ups

Sun Pharmaceutical: innovation pipeline

Cipla: local manufacturing

Key Cinacalcet Companies6 items

Amgen

Teva

Mylan

Aurobindo Pharma

Sun Pharmaceutical

Cipla

Market Ecosystem

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Cinacalcet formulations

Technology providers — develop drug delivery systems

System integrators / EPCs — ensure regulatory compliance

Distributors / channel partners — manage logistics and supply chain

Service providers / after-sales — offer patient support programs

Regulators/standards bodies — oversee safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents